[{"address1": "295 Rokeby Road", "address2": "Suite 1", "city": "Subiaco", "state": "WA", "zip": "6008", "country": "Australia", "phone": "61 8 6555 2950", "fax": "61 8 6166 0261", "website": "https://argentbiopharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Argent BioPharma Limited, a clinical-stage biopharmaceutical company, develops nano-engineered therapeutics that reset the balance between the nervous and immune systems in Malta, Slovenia, Australia, and internationally. The company's principal product candidates include CimetrA, which is in phase III clinical trial for the treatment of acute lung injury and ARDS; CannEpil, which is in phase I clinical trial for refractory epilepsy; and CogniCann, which is in phase IIA clinical trial for the symptomatic relief of Dementia and Alzheimer's. It is also involved in the preclinical development of Irnican for the treatment of Glioblastoma Multiforme; and R&D, which focuses on wound treatment. The company has collaborated with SINTEF to enhance antimicrobial therapies for chronic wounds and potential oncologic wound care. The company was formerly known as MGC Pharmaceuticals Limited and changed its name to Argent BioPharma Limited. Argent BioPharma Limited was founded in 2014 and is based in Subiaco, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Roby Reuven Zomer", "age": 44, "title": "Co-Founder, MD, CEO & Chairman", "yearBorn": 1980, "fiscalYear": 2025, "totalPay": 205879, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Igor  Bluvstein", "age": 42, "title": "Chief Financial Officer", "yearBorn": 1982, "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shachar  Shimony", "title": "Group General Counsel", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Amir  Polak", "title": "Chief Pharmaceutical Development Officer", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sabina  Suljakovic", "title": "Chief Quality and Commercial Officer", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Nadya  Lisovoder", "title": "Chief Medical Officer", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sasha  Friedman", "title": "Deputy CEO", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Yair  Tal", "title": "Chief Information Security Officer", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rowan  Harland", "title": "Company Secretary", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ana Arhar Oblak", "title": "Group Financial Controller", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.05785, "open": 0.1528, "dayLow": 0.1528, "dayHigh": 0.1528, "regularMarketPreviousClose": 0.05785, "regularMarketOpen": 0.1528, "regularMarketDayLow": 0.1528, "regularMarketDayHigh": 0.1528, "payoutRatio": 0.0, "beta": 0.58, "volume": 100, "regularMarketVolume": 100, "averageVolume": 2109, "averageVolume10days": 140, "averageDailyVolume10Day": 140, "bid": 0.011, "ask": 0.0965, "bidSize": 10000, "askSize": 400, "marketCap": 4498928, "fiftyTwoWeekLow": 0.0105, "fiftyTwoWeekHigh": 0.36, "allTimeHigh": 175.0, "allTimeLow": 0.0105, "priceToSalesTrailing12Months": 24.915836, "fiftyDayAverage": 0.0952408, "twoHundredDayAverage": 0.08422925, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 11438632, "profitMargins": 0.0, "floatShares": 24645494, "sharesOutstanding": 77768867, "heldPercentInsiders": 0.67374, "heldPercentInstitutions": 0.0, "impliedSharesOutstanding": 97444014, "bookValue": -0.12, "lastFiscalYearEnd": 1751241600, "nextFiscalYearEnd": 1782777600, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -17844296, "trailingEps": -0.2, "lastSplitFactor": "1:1000", "lastSplitDate": 1698624000, "enterpriseToRevenue": 63.349, "enterpriseToEbitda": -0.759, "52WeekChange": -0.8393055, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 0.05785, "recommendationKey": "none", "totalCash": 1024405, "totalCashPerShare": 0.014, "ebitda": -15080310, "totalDebt": 8287242, "quickRatio": 0.129, "currentRatio": 0.187, "totalRevenue": 180565, "revenuePerShare": 0.003, "returnOnAssets": -1.47518, "grossProfits": -601038, "freeCashflow": -4506415, "operatingCashflow": -9279624, "revenueGrowth": -0.395, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -39.00624, "financialCurrency": "AUD", "symbol": "RGTLF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "cryptoTradeable": false, "marketState": "CLOSED", "shortName": "Argent BioPharma Limited", "longName": "Argent BioPharma Limited", "corporateActions": [], "regularMarketTime": 1763154000, "exchange": "PNK", "messageBoardId": "finmb_146284473", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.05785, "firstTradeDateMilliseconds": 1487773800000, "regularMarketChange": 0.0, "regularMarketDayRange": "0.1528 - 0.1528", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 2109, "fiftyTwoWeekLowChange": 0.04735, "fiftyTwoWeekLowChangePercent": 4.509524, "fiftyTwoWeekRange": "0.0105 - 0.36", "fiftyTwoWeekHighChange": -0.30215, "fiftyTwoWeekHighChangePercent": -0.8393056, "fiftyTwoWeekChangePercent": -83.93055, "earningsTimestampStart": 1753657376, "earningsTimestampEnd": 1754002976, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.2, "fiftyDayAverageChange": -0.037390802, "fiftyDayAverageChangePercent": -0.39259225, "twoHundredDayAverageChange": -0.026379254, "twoHundredDayAverageChangePercent": -0.313184, "priceToBook": -0.48208335, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "MGC Pharmaceuticals Limited", "nameChangeDate": "2025-11-14", "hasPrePostMarketData": false, "displayName": "Argent BioPharma", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]